About
Orally delivered Biologics
Areas of Focus
Categories
BiosimilarsBiologics & BiopharmaceuticalDrug Delivery & FormulationBiotech
Team (16)
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
377
By Phase
PHASE1: 4NA: 1
By Status
COMPLETED: 4NOT_YET_RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06891287Lead Sponsor
An Early Phase Study of RT-114
PHASE1Not yet recruiting
60 participants
Started: Jun 1, 2025 · Completed: Apr 1, 2026
NCT05890118Lead Sponsor
Study Evaluating PK of Ustekinumab Administered Orally Via RaniPill™ Capsule
PHASE1Completed
55 participants
Started: Aug 30, 2023 · Completed: Nov 28, 2023
NCT05164614Lead Sponsor
Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule
PHASE1Completed
50 participants
Started: Feb 21, 2022 · Completed: Oct 17, 2022
NCT04911296Lead Sponsor
Pill Swallow Study
NACompleted
150 participants
Started: Jun 1, 2021 · Completed: Aug 27, 2021
NCT03798912Lead Sponsor
A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform
PHASE1Completed
62 participants
Started: Jul 9, 2019 · Completed: Feb 17, 2020
Locations (1)
Headquarters
San Jose, CA, United States
Map
Loading map...